FDA Inspection 1331348 — Osteogenics Biomedical, Inc.
The FDA completed an inspection of Osteogenics Biomedical, Inc. on Jul 31, 2026 in Lubbock, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 31, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Lubbock, TX (United States)